SU2C-American Cancer Society Lung Cancer Dream Team Discover New Strategy in Treating Lung Cancer Patients - Stand Up to Cancer

News

SU2C-American Cancer Society Lung Cancer Dream Team Discover New Strategy in Treating Lung Cancer Patients

Dr. Janne and the SU2C-American Cancer Society Lung Cancer Dream Team have been focused on treating lung cancer patients with mutant KRAS. In this new publication, they report that a subgroup of patients with mutant KRAS may benefit from drugs called MEK inhibitors, if these patients do not have as much of the non-mutant KRAS protein. This information is helpful in deciding what treatments can be used for certain patients with mutant KRAS.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.

Donate to SU2C using your Mastercard, and Mastercard will match up to $250,000 from 12/10 through 12/31, or until match is fulfilled.* Learn How